Welcome to LookChem.com Sign In|Join Free
  • or
Acetic acid, bromo(hydroxyimino)- (9CI) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

167953-86-8

Post Buying Request

167953-86-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

167953-86-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 167953-86-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,7,9,5 and 3 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 167953-86:
(8*1)+(7*6)+(6*7)+(5*9)+(4*5)+(3*3)+(2*8)+(1*6)=188
188 % 10 = 8
So 167953-86-8 is a valid CAS Registry Number.

167953-86-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name bromohydroximinoacetic acid

1.2 Other means of identification

Product number -
Other names Bromhydroxyiminoessigsaeure

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:167953-86-8 SDS

167953-86-8Upstream product

167953-86-8Relevant academic research and scientific papers

ISOXAZOLINES AS INHIBITORS OF FATTY ACID AMIDE HYDROLASE

-

Page/Page column 172; 178, (2010/12/18)

The present invention provides isoxazoline FAAH inhibitors of the formula (I): or pharmaceutically acceptable forms thereof, wherein each of G, Ra, Rb, Rc, and Rd are as defined herein. The present invention also provides pharmaceutical compositions comprising a compound of formula (I), or a pharmaceutically acceptable form thereof, and a pharmaceutically acceptable excipient. The present invention also provides methods for treating an FAAH-mediated condition comprising administering a therapeutically effective amount of a compound of formula (I), or pharmaceutically acceptable form thereof, to a subject in need thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 167953-86-8